| Literature DB >> 24999415 |
Susan Hart1, Richard C Franklin2, Janice Russell3, Suzanne Abraham4.
Abstract
BACKGROUND: Clear evidence based guidelines on the best and safest method of achieving and maintaining normal body weight during inpatient treatment of Anorexia Nervosa (AN) are currently not available. Oral feeding with food alone, high-energy liquid supplements, nasogastric feeding and parenteral nutrition all have the potential to achieve weight gain in the treatment of AN but the advantages and disadvantages of each method have not been comprehensively evaluated. A literature search was undertaken to identify papers describing feeding methods used during inpatient treatment of AN. The selection criteria searched for papers that described the feeding method; and reported weight change variables such as admission and discharge weight in kilograms, or Body Mass Index; or weight change over the course of inpatient treatment.Entities:
Keywords: Anorexia nervosa; Enteral; Feeding; Nasogastric; Parenteral; Refeeding
Year: 2013 PMID: 24999415 PMCID: PMC4081821 DOI: 10.1186/2050-2974-1-36
Source DB: PubMed Journal: J Eat Disord ISSN: 2050-2974
Papers meeting the inclusion criteria
| Castro-Fornieles, [ | Observational | Food | 49 | 14.4 | 15.5 | 18.4 | 8.7 | 29.8 | - |
| Castro, [ | Observational | Food | 101 | 14.9 | 15.9 | - | 6.3 | 31.2 | - |
| Courterier, [ | Chart review | NG + food | 12 | 15.7 | - | - | 5.5 | 78.0 | - |
| Dalle Grave, [ | Chart review | Food | 35 | 22.3 | 12.6 | - | 10.1 | 92.4 | - |
| Diamanti, [ | Chart review | PN + food | 104 | 14.9 | 14.3 | 15.6 | 3.1 | 30.7 | 2175 |
| Food | 94 | 15.2 | 16.0 | 16.3 | 1.2 | 15.6 | 2078 | ||
| Garber, [ | Observational | SUP + food | 35 | 16.2 | 16.3 | - | 2.4 | 16.7 | 2668 |
| Gentile, [ | Observational | NG + food | 33 | 22.8 | 11.3 | 13.5 | 5.4 | - | 1736 |
| Gentile, [ | Chart review | NG + food | 75 | 16.8 | 12.6 | 18.3 | 14.9 | - | - |
| Hart, [ | Observational | SUP + food | 96 | - | 15.1 | 16.9 | 4.2 | 48.7 | 2520 |
| Food | 318 | - | 16.6 | 17.8 | 3.3 | 38.0 | 1980 | ||
| Imbierowicz, [ | Chart review | SUP + food | 42 | 24.8 | 15.2 | - | 5.2 | 72.8 | - |
| Food | 42 | 23.7 | 15.3 | - | 3.5 | 82.6 | - | ||
| Krahn, [ | Observational | Food | 10 | - | 15.4 | 19.4 | 10.4 | - | 3600 |
| Lay, [ | Chart review | Food | 40 | 15.2 | 13.6 | 17.2 | 9.4 | 141.0 | - |
| Lund, [ | Prospective | NG + food | 79 | 21.6 | 16.3 | 20.8 | 12.2 | 103.4 | - |
| Neiderman, [ | Survey | NG + food | 19 | 13.6 | 15.4 | 17.5 | - | - | - |
| Okamoto, [ | Observational | SUP + food | 21 | 20.5 | 13.5 | 16.7 | - | 108.9 | - |
| Food 1 | 7 | 18.4 | 12.9 | 15.7 | - | 149.0 | - | ||
| Food 2 | 7 | 18.2 | 14.5 | 16.0 | - | 70.4 | - | ||
| Ornstein, [ | Chart review | NG + food | 69 | 15.5 | 15.0 | 16.9 | 4.9 | 25.6 | - |
| Ostuzzi, [ | Observational | SUP + food | 53 | 24.7 | - | - | 6.2 | 101.9 | - |
| Pertushuk, [ | Chart review | PN + food | 23 | 25.4 | - | - | 2.5 | 62.6 | - |
| Food | 136 | 23.8 | - | - | 1.1 | 29.6 | - | ||
| Rigaud, [ | RCT | NG + food | 19 | - | 15.8 | 17.4 | - | - | 1832 |
| Food | 17 | - | 16.2 | 16.6 | - | - | 1642 | ||
| Rigaud, [ | RCT | NG + food | 41 | 22.5 | 12.1 | 17.9 | 9.6 | - | - |
| Food | 40 | 24.2 | 12.8 | 15.9 | 5.0 | - | - | ||
| Robb, [ | Chart review | NG + food | 52 | 14.8 | 15.5 | 17.5 | 5.4 | 22.3 | 3255 |
| Food | 48 | 15.0 | 16.0 | 16.8 | 2.4 | 22.1 | 2508 | ||
| Silber, [ | Chart review | NG + food | 6 | 13.8 | 15.3 | 19.1 | 10.9 | 36.0 | 4350 |
| Food | 8 | 14.9 | 17.4 | 18.5 | 3.8 | 39.9 | 3400 | ||
| Stordy, [ | Observational | Food | 11 | 19.9 | - | - | 12.8 | - | 2800 |
| Tonoike, [ | Chart review | PN + food | 46 | 21.0 | 12.7 | 17.2 | 11.1 | 63.5 | - |
| Walker, [ | Observational | SUP + food | 29 | - | - | - | 8.4 | - | - |
| Zeurcher, [ | Chart review | NG + food | 155 | 25.7 | 14.2 | - | 8.1 | 61.0 | 3035 |
| Food | 226 | 25.2 | 15.7 | - | 5.7 | 48.3 | 2815 |
Food = Food only; SUP = High-energy liquid supplements; NG = Nasogastric feeding; PN = Parenteral nutrition; RCT = Randomised controlled trial.
Summary of results
| N papers total | 6 | 6 | 11 | 3 | 26 |
| Total samples (including 10 comparator samples; n) | 17 | 6 | 11 | 3 | 37 |
| Papers with the primary aim to describe the feeding method? | 0 | 3 | 8 | 3 | 14 |
| Mean sample size (range) | 69.9 | 46.0 | 50.9 | 57.7 | 59.4 |
| (7 – 318) | (21 – 96) | (6 – 155) | (23 – 104) | (6 – 318) | |
| n = 17 | n = 6 | n = 11 | n = 3 | n = 37 | |
| Total number of participants for method | 1189 | 276 | 560 | 173 | 2198 |
| Mean length of stay in days (range) | 60.7 | 69.8 | 54.4 | 52.3 | 60.1 |
| (16–149) | (17 – 109) | (22 – 103) | (31 – 64) | (16 – 149) | |
| n = 13 | n = 5 | n = 6 | n = 3 | n = 27 | |
| Mean admission BMI (kg/m2) (range) | 15.1 | 15.0 | 14.4 | 13.5 | 14.7 |
| (12.6 – 17.4) | (13.5 – 16.3) | (11.3 – 16.3) | (12.7 – 14.3) | (11.3 - 17.4) | |
| n = 15 | n = 4 | n = 10 | n = 2 | n = 31 | |
| Mean discharge BMI (kg/m2) (range) | 17.4 | 16.8 | 17.7 | 16.4 | 17.4 |
| (15.7 – 20.3) | (16.7 – 16.9) | (13.5 – 20.8) | (15.6 – 17.2) | (13.5-20.8) | |
| n = 12 | n = 2 | n = 9 | n = 2 | n = 25 | |
| Mean total weight gain in kilograms (range) | 6.0 | 4.3 | 8.4 | 7.1 | 6.7 |
| (1.1 – 12.8) | (2.4- 6.2) | (4.9 – 14.9) | (3.1-11.1) | (1.1 – 14.9) | |
| n = 11 | n = 3 | n = 8 | n = 2 | n = 24 | |
| Mean energy intake (kCals) (range) | 2603 | 2594 | 2842 | 2175 | 2650 |
| (1642–3600) | (2520–2668) | (1736–4350) | - | (1642–4350) | |
| n = 8 | n = 2 | n = 5 | n = 1 | n = 16 |
Food = Food only; SUP = High-energy liquid supplements; NG = Nasogastric feeding; PN = Parenteral nutrition.
Benefits and adverse effects of four feeding methods
| • It teaches skills for eating, promotes normal behaviour, and challenges unhelpful coping strategies [ | • Less energy is delivered from food when compared with nasogastric feeding [ | |
| • Patients experience the amount of food necessary for weight gain and weight maintenance [ | | |
| • Food makes hospital meal management home-like and realistic, which exposes patients to a situation which is anxiety-provoking, and gives them confidence at managing meals at home [ | | |
| • Supplements can meet the high-energy requirements required for weight gain in a smaller volume than food [ | • The frequent use of supplements encourages patients away from the experience of food, re-enforces their avoidance of food and can foster dependency on artificial food sources [ | |
| • They are helpful as a “top-up for patients struggling with satiety and the quantities of food required to promote weight gain [ | | |
| • It can be seen as a type of medicine [ | | |
| • More comfortable for the patient with less pain, physical discomfort and abdominal distension than large amounts of food [ | • It interferes with the fragile alliance between the patient and treatment team [ | |
| | • The patient may feel disempowered and embittered towards the treatment team, which may have an impact on future personal and professional relationships [ | |
| • A helpful strategy aiding recovery: | | |
| | | |
| | • It is invasive, frightening, unpleasant and mirrors the dynamics of trauma [ | |
| | | |
| | • There is an emotional toll on staff treating involuntary patients [ | |
| • Opinions from patients and carers: | • Not helpful for long term recovery: | |
| | | |
| | | |
| | | |
| | • Medical complications i.e. aspiration [ | |
| | • The tube may not be inserted properly which is more likely when patients have one inserted against their will [ | |
| | • Opinions from patients and carers: | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| • It requires minimal patient cooperation [ | • It may reinforce a tendency to focus only on physical symptoms rather then the psychiatric implications of AN [ | |
| | • Sabotage occurs by pouring solutions into the sink and removing the device [ | |
| | • It cannot teach patients anything about eating, food choice or portion size, or to perceive their bodies more accurately [ | |
| | • Medical complications i.e. infections, arterial injury, cardiac arrhythmias (from placement), changes in vascular endothelium, hyper-osmolarity, and hyperglycaemia [ | |
| | • More medically intensive [ | |
| • Financial cost [ | ||